Multiple Choice
Monitoring of a patient who is on a lipid-lowering drug includes:
A) Fasting total cholesterol every 6 months
B) Lipid profile with attention to serum LDL 6 to 8 weeks after starting therapy, then again in 6 weeks
C) Complete blood count, C-reactive protein, and erythrocyte sedimentation rate after 6 weeks of therapy
D) All of the above
Correct Answer:

Verified
Correct Answer:
Verified
Q6: First-line therapy for hyperlipidemia is:<br>A) Statins<br>B) Niacin<br>C)
Q7: Which the following persons should not have
Q8: James is a 45-year-old patient with an
Q9: When starting a patient on a statin,
Q10: When considering which cholesterol-lowering drug to prescribe,
Q12: Jose is a 12-year-old overweight child with
Q13: What is considered the order of statin
Q14: Joanne is a 60-year-old patient with an
Q15: Phil is a 54-year-old male with multiple
Q16: Before starting therapy with a statin, the